[ad_1] U.S. inflation has come down, but not enough for voters to stop complaining about high prices.…
Tag:
Outbreaks/Epidemics
-
-
STOCK MARKET
Higher interest rates, inflation will challenge the post-COVID economy. AI will save it.
by userby user[ad_1] The post-COVID economy is emerging as Americans’ pandemic-era savings dwindle, while work-from-home activity moderates and…
-
STOCK MARKET
Sharing COVID therapy secrets is a Trojan horse that would gut U.S. biotech
by userby user[ad_1] “It’s time for the Biden administration to nix this misguided IP waiver once and…
-
STOCK MARKET
Crude oil sees first real ‘death cross’ since the pandemic plunge of early 2020
by userby user[ad_1] Charts of crude-oil futures have just flashed a bearish signal the likes of which…
-
STOCK MARKET
My friend was scared to death of COVID. I told him to get a colonoscopy.
by userby user[ad_1] When I came down with COVID-19 recently, I heard from a concerned friend who…
-
STOCK MARKET
New York City wants its residents to live longer and healthier, and the rest of the country may follow.
by userby user[ad_1] New York City is launching a broad public health campaign to increase longevity to…
-
STOCK MARKET
The Fed’s narrow view of inflation threatens to snatch defeat from the jaws of economic victory
by userby user[ad_1] The COVID pandemic business cycle was unprecedented across multiple dimensions: A major public health…
-
STOCK MARKET
Cinemark well-positioned for post-pandemic growth, could bring back dividend, says one analyst
by userby user[ad_1] Cinemark Holdings Inc. is well-positioned for growth as the movie-theater chain recovers from the…
-
STOCK MARKET
Biotech stocks are in a post-pandemic slump and recovery in 2024 is questionable
by userby user[ad_1] Novavax NVAX, +5.24% stands out as a stark reminder of the biotech sector’s faltering…
-
STOCK MARKET
Pfizer to more than double price of its COVID antiviral once drug moves to commercial market
by userby user[ad_1] Pfizer Inc. will charge $1,390 for a five-day course of its Paxlovid COVID-19 antiviral…